Align Technology, Inc. (ALGN) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Align Technology, Inc. (ALGN) Healthcare & Pipeline Overview

Align Technology, Inc. is a medical device company specializing in clear aligner therapy and intraoral scanning systems. Its flagship Invisalign system and iTero scanners cater to orthodontists and general dentists globally, positioning the company as a leader in digital orthodontics within the broader healthcare sector.

What Is the Investment Thesis for ALGN?

Align Technology presents a compelling investment thesis centered on its leadership in the clear aligner market and the growing adoption of digital orthodontics. With a P/E ratio of 29.6 and a profit margin of 10.5%, the company demonstrates solid profitability. Key growth drivers include the expansion of Invisalign into new markets and demographics, increased utilization of iTero scanners in dental practices, and ongoing innovation in product development. The company's high gross margin of 67.7% provides financial flexibility for further investment in research and development. However, potential risks include competition from other clear aligner providers and the impact of economic downturns on consumer spending on elective orthodontic treatments. Investors should monitor the company's ability to maintain its market share and continue to innovate in the face of increasing competition.

Based on FMP financials and quantitative analysis

ALGN Key Highlights

Market Cap of $11.7B reflects Align Technology's significant presence in the medical device industry.

• P/E Ratio of 29.6 indicates investor expectations for future earnings growth.
• Profit Margin of 10.5% demonstrates the company's ability to generate profits from its operations.
• Gross Margin of 67.7% highlights the premium pricing and value proposition of Align Technology's products.
• Beta of 1.81 suggests that the stock is more volatile than the overall market.

Who Are ALGN's Competitors?

ALGN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ALGN's Key Strengths?

Leading market share in the clear aligner industry.

• Strong brand recognition and reputation.
• Innovative technology and product development capabilities.
• Extensive network of trained dental professionals.

What Are ALGN's Weaknesses?

High price point compared to traditional braces.

• Reliance on dental professionals for treatment planning and execution.
• Potential for increased competition from other clear aligner providers.
• Exposure to economic downturns and consumer spending patterns.

What Could Drive ALGN Stock Higher?

Expansion into new international markets, particularly in Asia-Pacific and Latin America, driving revenue growth.

• Continued innovation in Invisalign technology, including new materials and treatment planning software.
• Increasing adoption of iTero scanners in dental practices, leading to higher scanner sales and service revenue.
• Potential regulatory approvals for new Invisalign products or features.
• Strategic partnerships with dental service organizations (DSOs) to expand market reach.

What Are the Key Risks for ALGN?

Rich valuation — a P/E of 29.6 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.

• Increased competition from other clear aligner providers, leading to price erosion and market share loss.
• Technological advancements that could disrupt the clear aligner market.
• Changes in regulatory requirements that could impact the sale or use of Invisalign and iTero products.
• Economic downturns that could reduce consumer spending on elective orthodontic treatments.
• Product liability claims related to Invisalign or iTero products.

What Are the Growth Opportunities for ALGN?

• Expanding Invisalign into new markets represents a significant growth opportunity for Align Technology. Emerging markets, particularly in Asia-Pacific and Latin America, offer substantial potential for increased adoption of clear aligner therapy. The company can leverage its existing infrastructure and partnerships to penetrate these markets and capitalize on the growing demand for orthodontic treatment. This expansion can contribute significantly to revenue growth over the next 3-5 years, with the potential to add millions of new patients to the Invisalign platform.
• Increasing the utilization of iTero scanners in dental practices is another key growth driver. The iTero scanner provides a range of benefits for dentists, including improved accuracy, faster turnaround times, and enhanced patient communication. By promoting the adoption of iTero scanners, Align Technology can increase its revenue from scanner sales and related services. The company can also leverage the iTero platform to develop new applications and features, further enhancing its value proposition for dental professionals. The market for intraoral scanners is expected to grow rapidly in the coming years, driven by the increasing adoption of digital dentistry.
• Developing new Invisalign products and features represents a continuous growth opportunity for Align Technology. The company can invest in research and development to create innovative solutions that address unmet needs in the orthodontics market. This includes developing new aligner materials, improving treatment planning software, and expanding the range of treatable cases. By staying at the forefront of technological innovation, Align Technology can maintain its competitive advantage and attract new customers. The company's commitment to innovation is essential for long-term growth and success.
• Strengthening partnerships with dental professionals is crucial for driving adoption of Invisalign and iTero products. Align Technology can collaborate with orthodontists and general dentists to provide training, support, and marketing assistance. By building strong relationships with dental professionals, the company can increase its brand awareness and generate referrals for Invisalign treatment. These partnerships can also provide valuable feedback for product development and improvement. The company's success depends on its ability to effectively engage with and support its network of dental professionals.
• Expanding the application of Invisalign and iTero technology beyond orthodontics presents a potential growth opportunity. Align Technology can explore new applications in areas such as restorative dentistry, cosmetic dentistry, and sleep apnea treatment. By leveraging its expertise in digital imaging and 3D printing, the company can develop innovative solutions for a wider range of dental and medical conditions. This expansion can diversify Align Technology's revenue streams and reduce its reliance on the orthodontics market. The company's ability to adapt its technology to new applications will be key to its long-term growth and success.

What Are ALGN's Competitive Advantages?

• Strong brand recognition and reputation in the clear aligner market.
• Proprietary technology and intellectual property related to Invisalign and iTero products.
• Extensive network of trained and certified dental professionals.
• High switching costs for dental professionals who have invested in iTero scanners and Invisalign training.

What Does ALGN Do?

Founded in 1997 and headquartered in Tempe, Arizona, Align Technology, Inc. revolutionized orthodontics with the introduction of the Invisalign system. This innovative clear aligner therapy provides an alternative to traditional braces, offering a more discreet and comfortable teeth-straightening solution. The company operates through two primary segments: Clear Aligner and Scanners & Services. The Clear Aligner segment encompasses a range of Invisalign products, including comprehensive treatments for teenagers and adults, as well as specialized options like Invisalign First for younger patients. The Scanners & Services segment features the iTero intraoral scanner, a hardware platform used for restorative and orthodontic procedures. This segment also offers software solutions for digital records storage, orthodontic diagnosis, and the fabrication of printed models and retainers. Align Technology sells its products in the United States, Switzerland, China, and internationally, serving orthodontists, general practitioner dentists, and other dental professionals. The company's focus on innovation and digital technology has established it as a key player in the evolving landscape of orthodontic care.

What Products and Services Does ALGN Offer?

• Designs, manufactures, and markets Invisalign clear aligners.
• Provides iTero intraoral scanners and related services.
• Offers comprehensive Invisalign treatment for teenagers and adults.
• Develops specialized Invisalign products for younger patients.
• Provides software solutions for digital records storage and orthodontic diagnosis.
• Offers computer-aided design and computer-aided manufacturing services.
• Sells ancillary products such as cleaning materials and adjusting tools.

How Does ALGN Make Money?

• Generates revenue from the sale of Invisalign clear aligners to orthodontists and general dentists.
• Earns revenue from the sale of iTero intraoral scanners and related software subscriptions.
• Provides training and support services to dental professionals.
• Sells ancillary products such as cleaning materials and adjusting tools.

What Industry Does ALGN Operate In?

Align Technology operates within the medical device industry, specifically in the orthodontics market. The industry is experiencing a shift towards digital solutions, with increasing adoption of clear aligner therapy and intraoral scanning technology. The global orthodontics market is projected to grow in the coming years, driven by factors such as increasing awareness of oral health, rising disposable incomes, and technological advancements. Align Technology competes with traditional orthodontic companies and other clear aligner providers. The company's focus on innovation, brand recognition, and global expansion positions it as a key player in this evolving market.

Who Are ALGN's Key Customers?

• Orthodontists who use Invisalign to treat patients.
• General practitioner dentists who offer Invisalign as a teeth-straightening option.
• Dental labs that utilize iTero scanners for digital impressions.
• Patients seeking a discreet and comfortable alternative to traditional braces.

Company Profile

Align Technology, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Tempe, US. The company is led by CEO Joseph Hogan. ALGN has traded publicly since 2001.

Return on equity for Align Technology, Inc. stands at 10.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.8%, showing how much profit it generates from its asset base. ALGN trades at a trailing price-to-earnings ratio of 29.59, above the Healthcare sector average of ~23x. Its free cash flow yield is 5.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.39 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.4%, the inverse of the P/E and a quick read on earnings relative to price.

ALGN Valuation & Market Position

With a $11.7B market cap, Align Technology, Inc. sits in the large-cap segment of the market. Relative to its peer group, ALGN's quantitative score of 85/100 is roughly in line with the peer average of 86/100.

Quarterly Financial Performance: Align Technology, Inc.

Revenue for Align Technology, Inc. came in at $1.06B during Q2 2026, a 1.5% improvement versus the preceding quarter. The company recorded net income of $108.3M, with diluted EPS of $1.51. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, ALGN averaged $1.44 in diluted EPS.

Align Technology, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.98 places it in the safe zone, indicating low near-term bankruptcy risk.

Align Technology, Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 4.7% above estimates on average.

Wall Street analysts project Align Technology, Inc. revenue of about $4.17B for fiscal 2026, with EPS near $11.28. The estimate reflects 12 contributing analysts.

Over the past six months, Align Technology, Inc. insiders filed 15 SEC Form 4 transactions — 5 sales and 10 purchases. On net that is roughly 9K shares acquired (about $0) — insiders putting money in tends to read as conviction.

ALGN Financials

ALGN Latest News

ALGN Analyst Consensus

ALGN MoonshotScore

Latest Align Technology, Inc. Analysis

ALGN Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources